Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Hana Biosciences second-quarter net loss decreases to $6.3 million

Hana Biosciences Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and six months ended June 30, 2010, and provided a corporate update.

13 Aug 2010

U.S.-funded center to improve Haitian garment manufacturing opens in Haiti

The U.S.-funded Haitian Apparel Center, which aims to train about 2,000 workers per year, was opened in the capital of Port-au-Prince on Wednesday, the Associated Press reports. The new center will help Haitian companies evolve from making "simple things, like sheets and T-shirts, to more complex garments," according to U.S. Ambassador Kenneth Merten. "And more complex garments mean higher profit margins and more money coming into the country," he added (Lush, 8/11).

13 Aug 2010

NovaBay second-quarter net loss increases to $1.2 million

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported second quarter financial results and highlighted the clinical progress of its in-house programs.

13 Aug 2010

Emergent BioSolutions enters agreement to acquire Trubion Pharmaceuticals

Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.

13 Aug 2010

Survey finds high level of noncompliance with PPE protocols among safety professionals

Nearly all of the safety professionals in a survey released today said that workers in their organizations had at some point failed to wear the necessary safety equipment while on the job. An exceedingly high 98 percent of respondents who attended the recent American Society of Safety Engineers (ASSE) show in Baltimore answered "yes" when asked if they had observed workers not wearing safety equipment when they should have been, according to the survey, which was conducted by Kimberly-Clark Professional.

12 Aug 2010

International cultivator wins Canada's prestigious medical marijuana quality award

An internationally-respected hydroponics medical marijuana cultivation educator won Canada's most prestigious medical marijuana quality award during a Toronto hydroponics expo competition...and he used a brand new type of hydroponics nutrients to do it.

12 Aug 2010

Simcere second-quarter total revenue increases 28.3% to RMB544.6 million

12 Aug 2010

NPL CaviMeter fine-tunes equipment to produce right quantity and distribution of cleaning action

Ultrasonic Cleaning Systems are widely used in healthcare applications during the sterilization of surgical instruments, and in many manufacturing and process industries. They work by passing a high frequency sound wave through a liquid detergent to create thousands of small bubbles. The sound waves then makes the bubbles implode with such force, that the impacts remove contaminant particles from submerged materials.The current NHS-recommended technique to measure the performance of ultrasonic cleaning systems uses aluminium foil, which is eroded and punctured by the imploding bubbles. This is an unreliable process to apply and can contaminate the vessel cleaning fluid, adding unnecessary costs.

12 Aug 2010

Simcere subsidiary receives Chinese SFDA approval to manufacture and market Palonosetron

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.

12 Aug 2010

Endologix responds to Bard Peripheral Vascular's patent infringement lawsuit

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, responded to the Bard Peripheral Vascular, Inc. lawsuit filed against Endologix in the United States District Court of Arizona. The Bard Peripheral lawsuit alleges that Endologix's proprietary high density ePTFE graft material, which is used for the Powerlink® System, infringes on Bard Peripheral's "Prosthetic Vascular Graft" patent (U.S. Patent No. 6,436,135).

12 Aug 2010

Seattle Genetics, Genentech expand antibody-drug conjugate collaboration

Seattle Genetics, Inc. announced today that it has expanded its antibody-drug conjugate (ADC) collaboration agreement with Genentech, Inc., a member of the Roche Group. Under the expanded agreement, Genentech will pay an upfront fee of $12 million for rights to utilize Seattle Genetics' ADC technology with additional antigens to be named by Genentech.

12 Aug 2010

TLV, Emergent BioSolutions form joint venture to develop broad spectrum pandemic flu vaccine

Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.

12 Aug 2010

Advaxis, Vibalogics to develop storage-stable formulation for live Listeria vaccines

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company and Vibalogics GmbH, a German biologics manufacturing company, have agreed to co-develop a room temperature stable, processing technology for live vaccines originally engineered for Advaxis.

12 Aug 2010

Protox reports $1.1M net income for second-quarter 2010 vs. $1.8M net loss for second-quarter 2009

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today released financial results for the second quarter 2010, ended June 30, 2010.

11 Aug 2010

Winner Medical third-quarter net sales increase 27.0% to $30.9 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries in China, today reported that third quarter fiscal year 2010 revenue year-on-year increased 27.0%, to $30.9 million, net income increased 10.1% to $3.4 million and a sales of PurCotton products year-on-year increased 114.0%, to $2.6 million.

11 Aug 2010

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.

11 Aug 2010

New computerized approach for dental restoration procedures

Oral surgeons may one day have an easier, less costly approach to one important aspect of dental restoration, thanks to a newly patented process developed by researchers at Missouri University of Science and Technology (Missouri S&T).The process computerizes the method for creating a dental bar, also called an over-denture. For dental restoration procedures, the device is the bridge connecting dental implants to dentures.

11 Aug 2010

Lutronic second-quarter revenues increase 15% to $11.5 million

Lutronic Corp commenced the month by announcing second-quarter financial results for the three month period, ending June 30, 2010.

11 Aug 2010

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Sinobiopharma, Inc., an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wholly-owned subsidiary Dong Ying Pharmaceutical Co., Ltd., has signed an agreement with Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to co-develop, manufacture and commercialize Eplerenone, a therapeutic agent formulated to treat high blood pressure and vascular diseases.

11 Aug 2010

Omeros net loss for second-quarter 2010 increases to $7.8 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.

11 Aug 2010

Manufacturing News and Research

Further Reading

Hana Biosciences second-quarter net loss decreases to $6.3 million

U.S.-funded center to improve Haitian garment manufacturing opens in Haiti

NovaBay second-quarter net loss increases to $1.2 million

Emergent BioSolutions enters agreement to acquire Trubion Pharmaceuticals

Survey finds high level of noncompliance with PPE protocols among safety professionals

International cultivator wins Canada's prestigious medical marijuana quality award

Simcere second-quarter total revenue increases 28.3% to RMB544.6 million

NPL CaviMeter fine-tunes equipment to produce right quantity and distribution of cleaning action

Simcere subsidiary receives Chinese SFDA approval to manufacture and market Palonosetron

Endologix responds to Bard Peripheral Vascular's patent infringement lawsuit

Seattle Genetics, Genentech expand antibody-drug conjugate collaboration

TLV, Emergent BioSolutions form joint venture to develop broad spectrum pandemic flu vaccine

Advaxis, Vibalogics to develop storage-stable formulation for live Listeria vaccines

Protox reports $1.1M net income for second-quarter 2010 vs. $1.8M net loss for second-quarter 2009

Winner Medical third-quarter net sales increase 27.0% to $30.9 million

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

New computerized approach for dental restoration procedures

Lutronic second-quarter revenues increase 15% to $11.5 million

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Omeros net loss for second-quarter 2010 increases to $7.8 million

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®